Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region

Blot, 1994, Esophageal cancer trends and risk factors, Semin Oncol, 2, 403

Heitmiller, 1996, Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma, J Thorac Cardiovasc Surg, 112, 130, 10.1016/S0022-5223(96)70187-3

Haggitt, 1994, Barrett's esophagus, dysplasia and adenocarcinoma, Hum Pathol, 25, 982, 10.1016/0046-8177(94)90057-4

Spechler, 1994, Barrett's esophagus, Gastroenterologist, 2, 273

Hamilton, 1987, The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus, Am J Clin Pathol, 87, 301, 10.1093/ajcp/87.3.301

Hameeteman, 1989, Barrett's esophagus: development of dysplasia and adenocarcinoma, Gastroenterology, 96, 1249, 10.1016/S0016-5085(89)80011-3

Blount, 1991, 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma, Cancer Res, 51, 5482

Younes, 1993, p53 protein accumulation in Barrett's metaplasia, dysplasia and carcinoma: a follow-up study, Gastroenterology, 105, 1637, 10.1016/0016-5085(93)91058-P

Hamelin, 1994, TP53 gene mutations and p53 protein immunoreactivity in malignant, and premalignant Barrett's epithelium, Gastroenterology, 107, 1012, 10.1016/0016-5085(94)90225-9

Moskaluk, 1996, p53 and p21WAF1/CIP1/SDI1 gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction, Hum Pathol, 27, 1211, 10.1016/S0046-8177(96)90317-2

Neshat, 1994, P53 mutations in Barrett's adenocarcinoma and high-grade dysplasia, Gastroenterology, 106, 1589, 10.1016/0016-5085(94)90415-4

Galipeau, 1996, 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus, Proc Natl Acad Sci, 93, 7081, 10.1073/pnas.93.14.7081

Schneider, 1996, Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases, J Thorac Cardiovasc Surg, 111, 323, 10.1016/S0022-5223(96)70441-5

Ireland, 1997, Barrett's esophagus: the significance of p53 in clinical practice, Ann Surg, 225, 17, 10.1097/00000658-199701000-00003

Barrett, 1996, Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genomic amplification and microsatellite polymorphisms, Oncogene, 12, 1873

Hammound, 1996, Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequence on the long arm of chromosome 4, Cancer Res, 56, 4499

Huang, 1992, Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers, Cancer Res, 52, 6525

Meltzer, 1996, The molecular biology of esophageal carcinoma, Recent Results Cancer Res, 142, 1, 10.1007/978-3-642-80035-1_1

Montesano, 1996, Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review, Int J Cancer, 69, 225, 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6

Barrett, 1996, Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus, Oncogene, 13, 1867

Powell, 1994, APC gene mutations in the mutation cluster region are rare in esophageal cancers, Gastroenterology, 107, 1759, 10.1016/0016-5085(94)90818-4

Barrett, 1996, Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma, Cancer Res, 56, 4351

Gleeson, 1996, Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma, Cancer Res, 56, 259

Meltzer, 1994, Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinoma, Cancer Res, 54, 3379

Keller, 1995, Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract: relation to clinicopathological data and family history, Am J Pathol, 147, 593

Hamilton, 1988, Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction, Hum Pathol, 19, 942, 10.1016/S0046-8177(88)80010-8

Hermanek, 1992

Hermanek, 1993

Moskaluk, 1997, Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections, Am J Pathol, 150, 1547

Bankfalvi, 1994, Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry, J Pathol, 174, 223, 10.1002/path.1711740312

Baas, 1994, An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms, J Pathol, 172, 5, 10.1002/path.1711720104

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452

Mantel, 1959, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22, 719

Cox, 1972, Regression models and life tables (with discussion), J R Stat Soc, 34, 187

Jessurun, 1992, Cecal poorly differentiated adenocarcinoma, medullary type, Mod Pathol, 5, 43A

Cameron, 1985, The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus, N Engl J Med, 313, 857, 10.1056/NEJM198510033131404

Cameron, 1995, Adenocarcinoma of the esophagogastric junction and Barrett's esophagus, Gastroenterology, 109, 1541, 10.1016/0016-5085(95)90642-8

Reid, 1992, Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort, Gastroenterology, 102, 1212, 10.1016/0016-5085(92)90758-Q

Blount, 1993, Clonal ordering of 17p and 5q allelic loses in Barrett dysplasia and adenocarcinoma, Proc Natl Acad Sci, 90, 3221, 10.1073/pnas.90.8.3221

Blount, 1994, 17p allelic losses in dipoid cells of patients with Barrett's esophagus who develop aneuploidy, Cancer Res, 54, 2292

Zhuang, 1996, Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma, Cancer Res, 56, 1961

Gleeson, 1998, Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia–dysplasia–carcinoma sequence, Genes Chromosomes Cancer, 21, 49, 10.1002/(SICI)1098-2264(199801)21:1<49::AID-GCC7>3.0.CO;2-8

Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I

Gleeson, 1995, Base transitional at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma, Cancer Res, 55, 3406

Kim, 1994, Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences, Am J Pathol, 145, 148

Thibodeau, 1993, Microsatellite instability in cancer of the proximal colon, Science, 260, 816, 10.1126/science.8484122

Dos Santos, 1996, Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis, Gastroenterology, 110, 38, 10.1053/gast.1996.v110.pm8536886

Heitmiller, 1996, Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy, Ann Surg, 224, 66, 10.1097/00000658-199607000-00010

Pera, 1992, Barrett's esophagus with high-grade dysplasia: an indication for esphagectomy?, Ann Thorac Surg, 54, 199, 10.1016/0003-4975(92)91370-O

Altorki, 1991, High-grade dysplasia in the columnar-lined esophagus, Am J Surg, 161, 97, 10.1016/0002-9610(91)90367-M

Overholt, 1996, Photodynamic therapy for Barrett's esophagus: clinical update, Am J Gastroenterol, 91, 1719

Levine, 1993, An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus, Gastroenterology, 105, 40, 10.1016/0016-5085(93)90008-Z

Paraf, 1995, Surgical pathology of adenocarcinoma arising in Barrett's esophagus, Am J Surg Pathol, 19, 183, 10.1097/00000478-199502000-00007

Coggi, 1997, p53 protein accumulation and p53 gene mutation in esophageal carcinoma, Cancer, 79, 425, 10.1002/(SICI)1097-0142(19970201)79:3<425::AID-CNCR1>3.0.CO;2-H